APA (7th ed.) Citation

Ilerhunmwuwa, N. P., Rayapureddy, A. K., Uche, I. N., Wasifuddin, M., & Wang, J. (2023). Cardiovascular-Related Mortality Risk in Primary Myelofibrosis in Pre-Ruxolitinib and Ruxolitinib Eras. Blood, 142(Supplement 1), 552. https://doi.org/10.1182/blood-2023-174418

Chicago Style (17th ed.) Citation

Ilerhunmwuwa, Nosakhare Paul, Aditya Keerthi Rayapureddy, Ifeanyi Nnamdi Uche, Mustafa Wasifuddin, and Jen-Chin Wang. "Cardiovascular-Related Mortality Risk in Primary Myelofibrosis in Pre-Ruxolitinib and Ruxolitinib Eras." Blood 142, no. Supplement 1 (2023): 552. https://doi.org/10.1182/blood-2023-174418.

MLA (9th ed.) Citation

Ilerhunmwuwa, Nosakhare Paul, et al. "Cardiovascular-Related Mortality Risk in Primary Myelofibrosis in Pre-Ruxolitinib and Ruxolitinib Eras." Blood, vol. 142, no. Supplement 1, 2023, p. 552, https://doi.org/10.1182/blood-2023-174418.